Conceptio
›
pancreatic-ductal-adenocarcinoma
Topic
pancreatic-ductal-adenocarcinoma
Knowledge-graph topic
· documents ABOUT pancreatic-ductal-adenocarcinoma across the archive
104
Documents about pancreatic-ductal-adenocarcinoma
Documents about pancreatic-ductal-adenocarcinoma
PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)
#982636
ClinicalTrials.gov
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
#835494
ClinicalTrials.gov
Hyperpolarized 13C MRI to Predict Response in Pancreatic Cancer
#905994
ClinicalTrials.gov
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
#874128
ClinicalTrials.gov
Utility of ctDNA in Early Switch of First-line mFOLFIRINOX in Metastatic Pancreatic Ductal Adenocarcinoma
#911402
ClinicalTrials.gov
Combination Therapy in Patients With Localized Pancreatic Ductal Adenocarcinoma
#849550
ClinicalTrials.gov
Study of Pembrolizumab With or Without Defactinib Following Chemotherapy as a Neoadjuvant and Adjuvant Treatment for Resectable Pancreatic Ductal Adenocarcinoma
#353294
ClinicalTrials.gov
How Does Pre-operative Biliary Drainage in Pancreatic Adenocarcinoma Affect Surgical Outcomes in Pancreatic Cancer Surgery
#840624
ClinicalTrials.gov
A Prospective Registry for Patients at High-Risk for Pancreatic Cancer
#915712
ClinicalTrials.gov
Samuraciclib for the Treatment of Patients With Resectable, Borderline Resectable, or Locally Advanced Basal Pancreatic Cancer
#884408
ClinicalTrials.gov
Phase II Study of MEDI4736 Monotherapy or in Combinations With Tremelimumab in Metastatic Pancreatic Ductal Carcinoma
#966828
ClinicalTrials.gov
Combined MEK, STAT3 and PD-1 Inhibition in Metastatic Pancreatic Ductal Adenocarcinoma
#870632
ClinicalTrials.gov
Combination Therapy for Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma
#860721
ClinicalTrials.gov
Intraperitoneal Paclitaxel With NALIRIFOX for Pancreatic Ductal Adenocarcinoma With Peritoneal Carcinomatosis
#884239
ClinicalTrials.gov
PRaG Therapy in Combination With Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC) (NeoPRAG Study)
#842223
ClinicalTrials.gov
AI Derived Biomarker to Select Neoadjuvant Treatment for Borderline Resectable Pancreatic Ductal Adenocarcinoma
#966162
ClinicalTrials.gov
Expanded Access to Mifomelatide for Cachexia in Adults With Advanced PDAC
#883352
ClinicalTrials.gov
Observational Registry Evaluating the Clinical Impact of the Blood-Based Biomarker Test for Early-Stage Pancreatic Ductal Adenocarcinoma
#855552
ClinicalTrials.gov
Hyperpolarized 13C Pyruvate MRI for Treatment Response Assessment in Pancreatic Ductal Adenocarcinoma
#890882
ClinicalTrials.gov
Prospective Evaluation of MRI Biomarkers in Pancreatic Ductal Adenocarcinoma
#808030
ClinicalTrials.gov
OMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma
#908650
ClinicalTrials.gov
ONT01 and Gemcitabine/Nab-paclitaxel as Second Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma
#405139
ClinicalTrials.gov
RPSA as a Potential Prognostic Biomarker of Pancreatic Cancer
#873882
ClinicalTrials.gov
The Effects of Neoadjuvant Metformin on Tumour Cell Proliferation and Tumour Progression in Pancreatic Ductal Adenocarcinoma
#67834
ClinicalTrials.gov
Sonoporation and Chemotherapy for the Treatment of Pancreatic Cancer
#869697
ClinicalTrials.gov
Predictive Factors for Resection and Survival in Type A Borderline Resectable Pancreatic Ductal Adenocarcinoma Patients After Neoadjuvant Therapy
#865049
ClinicalTrials.gov
Nab-Paclitaxel + Cisplatin + Gemcitabine in Untreated Metastatic Pancreatic Adenocarcinoma
#862366
ClinicalTrials.gov
ATRA and SDK002 in Combination With Chemotherapy and Anti-PD-1 Inhibitor in Patients With Advanced Pancreatic Ductal Adenocarcinoma.
#349977
ClinicalTrials.gov
Icaritin in Combination With AG in Patients With Previously Untreated Advanced Pancreatic Ductal Adenocarcinoma
#870526
ClinicalTrials.gov
Trial of Neoadjuvant and Adjuvant Nivolumab and BMS-813160 With or Without GVAX for Locally Advanced Pancreatic Ductal Adenocarcinomas.
#325149
ClinicalTrials.gov
Adaptive Radiation for Locally Advanced Unresectable Pancreatic Cancer
#913512
ClinicalTrials.gov
Cemiplimab Plus Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma
#911900
ClinicalTrials.gov
A Study of Abemaciclib (LY2835219) Alone or in Combination With Other Agents in Participants With Previously Treated Pancreatic Ductal Adenocarcinoma
#800909
ClinicalTrials.gov
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
#803150
ClinicalTrials.gov
Phase Ib/II Study of MEDI4736 Evaluated in Different Combinations in Metastatic Pancreatic Ductal Carcinoma
#407720
ClinicalTrials.gov
DC Vaccine in Pancreatic Cancer
#915889
ClinicalTrials.gov
Defining a Vascular Phenotype of Pancreatic Ductal Adenocarcinoma With CT Perfusion Using Quantitative Radiomics
#802025
ClinicalTrials.gov
CA-4948 Added to Standard Chemotherapy to Treat Metastatic or Unresectable Pancreatic Cancer
#979700
ClinicalTrials.gov
Cutting Edge Imaging With PET-FAPI for Earlier Pancreatic Cancer Diagnosis (INDIGO-FAPI)
#861688
ClinicalTrials.gov
Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma
#895285
ClinicalTrials.gov
Targeted therapy in pancreatic ductal adenocarcinoma: current advances and challenges
#667087
ULRR
Gene Expression Profiling of Pancreatic Ductal Adenocarcinoma Arising From Intraductal Papillary Mucinous Neoplasms of the Pancreas
#323742
ResearchOnline@ND
A Study Comparing Whole-Body Heat Treatment Plus Systemic Therapy to Systemic Therapy Alone, for Advanced Pancreatic Cancer
#864347
ClinicalTrials.gov
Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
#877329
ClinicalTrials.gov
Phase I - Escalating Dose Study of siG12D LODER (Local Drug EluteR) in Patients With Locally Advanced Adenocarcinoma of the Pancreas, and a Single Dose Study of siG12D LODER (Local Drug EluteR) in Patients With Non-operable Adenocarcinoma of the Pancreas
#910830
ClinicalTrials.gov
Expanded Access Protocol of ELI-002-102 in Subjects With KRAS/NRAS Mutated Pancreatic Ductal Adenocarcinoma
#249613
ClinicalTrials.gov
Pancreatic Ductal Adenocarcinoma - Microbiome as Predictor of Subtypes
#901649
ClinicalTrials.gov
PRedictiOn Algorithms for the DeTECTion of Early Stage Pancreatic Cancer
#870133
ClinicalTrials.gov
RNA Precision Oncology in Advanced Pancreatic Cancer
#918582
ClinicalTrials.gov
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
#898373
ClinicalTrials.gov
Page 1 of 5
Next →
Topic record
· derived from the Conceptio knowledge graph (shared subject terms across the corpus)
Conceptio Open Knowledge Archive — topic hubs link to canonical document pages with full provenance.